181 related articles for article (PubMed ID: 27640728)
1. Impact of Gene Editing Tools, Like CRISPR/Cas9, on the Public Health Response to Disease Outbreaks.
Pope SM
Disaster Med Public Health Prep; 2017 Apr; 11(2):155-159. PubMed ID: 27640728
[TBL] [Abstract][Full Text] [Related]
2. CRISPR/Cas9: an advanced tool for editing plant genomes.
Samanta MK; Dey A; Gayen S
Transgenic Res; 2016 Oct; 25(5):561-73. PubMed ID: 27012546
[TBL] [Abstract][Full Text] [Related]
3. CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery.
Wang HX; Li M; Lee CM; Chakraborty S; Kim HW; Bao G; Leong KW
Chem Rev; 2017 Aug; 117(15):9874-9906. PubMed ID: 28640612
[TBL] [Abstract][Full Text] [Related]
4. Exploring the potential of genome editing CRISPR-Cas9 technology.
Singh V; Braddick D; Dhar PK
Gene; 2017 Jan; 599():1-18. PubMed ID: 27836667
[TBL] [Abstract][Full Text] [Related]
5. Recent Progress in CRISPR/Cas9 Technology.
Mei Y; Wang Y; Chen H; Sun ZS; Ju XD
J Genet Genomics; 2016 Feb; 43(2):63-75. PubMed ID: 26924689
[TBL] [Abstract][Full Text] [Related]
6. Progress and prospects in plant genome editing.
Yin K; Gao C; Qiu JL
Nat Plants; 2017 Jul; 3():17107. PubMed ID: 28758991
[TBL] [Abstract][Full Text] [Related]
7. CRISPR-Cas9 gene editing: Delivery aspects and therapeutic potential.
Oude Blenke E; Evers MJ; Mastrobattista E; van der Oost J
J Control Release; 2016 Dec; 244(Pt B):139-148. PubMed ID: 27498021
[TBL] [Abstract][Full Text] [Related]
8. CRISPR/Cas9: An RNA-guided highly precise synthetic tool for plant genome editing.
Demirci Y; Zhang B; Unver T
J Cell Physiol; 2018 Mar; 233(3):1844-1859. PubMed ID: 28430356
[TBL] [Abstract][Full Text] [Related]
9. CRISPR: From Prokaryotic Immune Systems to Plant Genome Editing Tools.
Bandyopadhyay A; Mazumdar S; Yin X; Quick WP
Adv Exp Med Biol; 2017; 1016():101-120. PubMed ID: 29130156
[TBL] [Abstract][Full Text] [Related]
10. The application of somatic CRISPR-Cas9 to conditional genome editing in Caenorhabditis elegans.
Li W; Ou G
Genesis; 2016 Apr; 54(4):170-81. PubMed ID: 26934570
[TBL] [Abstract][Full Text] [Related]
11. Harnessing heterologous and endogenous CRISPR-Cas machineries for efficient markerless genome editing in Clostridium.
Pyne ME; Bruder MR; Moo-Young M; Chung DA; Chou CP
Sci Rep; 2016 May; 6():25666. PubMed ID: 27157668
[TBL] [Abstract][Full Text] [Related]
12. CRISPR-Cas9: from Genome Editing to Cancer Research.
Chen S; Sun H; Miao K; Deng CX
Int J Biol Sci; 2016; 12(12):1427-1436. PubMed ID: 27994508
[TBL] [Abstract][Full Text] [Related]
13. CRISPR/Cas9 Platforms for Genome Editing in Plants: Developments and Applications.
Ma X; Zhu Q; Chen Y; Liu YG
Mol Plant; 2016 Jul; 9(7):961-74. PubMed ID: 27108381
[TBL] [Abstract][Full Text] [Related]
14. Genome editing in Drosophila melanogaster: from basic genome engineering to the multipurpose CRISPR-Cas9 system.
Ren X; Holsteens K; Li H; Sun J; Zhang Y; Liu LP; Liu Q; Ni JQ
Sci China Life Sci; 2017 May; 60(5):476-489. PubMed ID: 28527116
[TBL] [Abstract][Full Text] [Related]
15. The tsunami named CRISPR/Cas9.
Chneiweiss H
Rev Neurol (Paris); 2018; 174(7-8):487-488. PubMed ID: 29779853
[No Abstract] [Full Text] [Related]
16. Analysis of microsatellite instability in CRISPR/Cas9 editing mice.
Huo X; Du Y; Lu J; Guo M; Li Z; Zhang S; Li X; Chen Z; Du X
Mutat Res; 2017 Mar; 797-799():1-6. PubMed ID: 28284774
[TBL] [Abstract][Full Text] [Related]
17. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.
Doetschman T; Georgieva T
Circ Res; 2017 Mar; 120(5):876-894. PubMed ID: 28254804
[TBL] [Abstract][Full Text] [Related]
18. The application of CRISPR/Cas9 in genome editing of filamentous fungi.
Li HH; Liu G
Yi Chuan; 2017 May; 39(5):355-367. PubMed ID: 28487268
[TBL] [Abstract][Full Text] [Related]
19. CRISPR/Cas9-mediated correction of human genetic disease.
Men K; Duan X; He Z; Yang Y; Yao S; Wei Y
Sci China Life Sci; 2017 May; 60(5):447-457. PubMed ID: 28534256
[TBL] [Abstract][Full Text] [Related]
20. Targeted genome editing in the rare actinomycete Actinoplanes sp. SE50/110 by using the CRISPR/Cas9 System.
Wolf T; Gren T; Thieme E; Wibberg D; Zemke T; Pühler A; Kalinowski J
J Biotechnol; 2016 Aug; 231():122-128. PubMed ID: 27262504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
